{"gene":"TBCB","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":2006,"finding":"TBCB forms a binary complex with TBCE that greatly enhances the efficiency of TBCE to dissociate tubulin heterodimers both in vivo and in vitro; TBCE, TBCB, and α-tubulin form a ternary complex after heterodimer dissociation, while free β-tubulin is recovered by TBCA.","method":"Overexpression, in vitro dissociation assays, co-immunoprecipitation, biochemical fractionation","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal complex formation confirmed by multiple biochemical methods, in vitro and in vivo, replicated in subsequent studies","pmids":["17184771"],"is_preprint":false},{"year":2006,"finding":"Overexpression of TBCB depolymerizes microtubules in vivo, demonstrating a direct role for TBCB in regulating microtubule dynamics.","method":"Overexpression in cells, immunofluorescence microscopy of microtubule network","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — clean overexpression with defined cellular phenotype, single lab","pmids":["17184771"],"is_preprint":false},{"year":2008,"finding":"TBCB binds CCT-generated folding intermediates of α-tubulin; the pachygyria-causing R264C mutation in TUBA1A fails to stably interact with TBCB, contributing to deficient tubulin heterodimer formation.","method":"In vitro folding assays with CCT, pulldown/binding assays with TBCB, mutagenesis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis establishing direct TBCB-αtubulin interaction and functional consequence","pmids":["18199681"],"is_preprint":false},{"year":2015,"finding":"Cryo-EM structure of the human TBCE–TBCB–α-tubulin (αEB) ternary complex reveals that heterodimer dissociation is energy-independent and is driven by steric clash between β-tubulin and the TBCE CAP-Gly and LRR domains; UBL domains of the chaperones protrude in a configuration suggesting direct interaction with the proteasome for α-tubulin degradation.","method":"Electron microscopy, image processing (3D reconstruction), X-ray crystallography of TBCE UBL domain, atomic docking, biochemical dissociation assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 — structure determined by EM with atomic docking and validated by biochemical assays, multiple orthogonal methods","pmids":["25908846"],"is_preprint":false},{"year":2017,"finding":"HILI (PIWIL2) interacts with TBCB and inhibits Gigaxonin-mediated ubiquitination and proteasomal degradation of TBCB by promoting HSP90–TBCB binding and blocking Gigaxonin–TBCB interaction; HILI also reduces PAK1-induced phosphorylation of TBCB, collectively increasing TBCB levels and destabilizing microtubules.","method":"Co-immunoprecipitation, ubiquitination assays, RNAi knockdown, overexpression, western blot, immunofluorescence","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2/3 — multiple co-IP and functional assays from single lab identifying post-translational regulation of TBCB","pmids":["28393858"],"is_preprint":false},{"year":2018,"finding":"Elevated TBCB leads to depolymerization and degradation of α-tubulin TUBA4A; excess TBCB causes motor axon defects in an in vivo model, placing TBCB upstream of TUBA4A stability in a miR-1825/TBCB/TUBA4A pathway.","method":"Proteomic and transcriptomic analysis, loss-of-function/gain-of-function in cell lines, in vivo motor axon phenotype assay, patient tissue validation","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (proteomics, cell-based, in vivo) from single lab","pmids":["30030593"],"is_preprint":false},{"year":2020,"finding":"The Salmonella effector SseK1 directly binds TBCB (identified by yeast two-hybrid) and catalyzes N-acetylglucosamine addition to arginine residues on TBCB; this modification promotes microtubule cytoskeleton stabilization in host cells, and requires the conserved DxD catalytic motif of SseK1.","method":"Yeast two-hybrid, glycosyltransferase activity assay, mutagenesis of DxD motif, immunofluorescence of microtubule network in HEK293T cells","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — enzymatic activity demonstrated with mutagenesis and functional readout, single lab","pmids":["32366039"],"is_preprint":false},{"year":2021,"finding":"Colchicine inhibits tubulin heterodimer dissociation by the TBCE/TBCB complex in vitro, likely by interfering with TBCE–tubulin dimer interactions; this leads to accumulation of free TBCA and reduced tubulin heterodimer recycling. Manipulation of TBCA levels by RNAi or overexpression decreases tubulin heterodimer levels, indicating the TBCE/TBCB+TBCA system controls the critical concentration of free tubulin heterodimers.","method":"In vitro dissociation assays with colchicine, RNAi knockdown and overexpression of TBCA, western blot, human cell treatment with colchicine/nocodazole/cycloheximide","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical assays with mechanistic dissection, supported by cell-based loss/gain-of-function, multiple orthogonal methods","pmids":["33968934"],"is_preprint":false},{"year":2025,"finding":"A homozygous p.Tyr197Asn variant in TBCB reduces TBCB protein levels in patient fibroblasts and causes a loss-of-function phenotype (benomyl hypersensitivity in the yeast ortholog ALF1); the homologous Drosophila mutant shows reduced survival and impaired motor function, establishing that TBCB is required for normal axonal function and CNS development.","method":"Exome sequencing, western blot and immunofluorescence in patient fibroblasts, yeast ALF1 ortholog benomyl sensitivity assay, CRISPR-Cas9 Drosophila mutant climbing/survival assay","journal":"Genetics in medicine","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function validated in patient cells and two model organisms with defined phenotypic readouts","pmids":["40856104"],"is_preprint":false},{"year":1996,"finding":"TBCB (CKAP1) was cloned from human fetal brain cDNA and found to encode a protein containing a CAP-Gly domain conserved among cytoskeleton-associated proteins; the gene was mapped to chromosome 19q13.11–q13.12.","method":"cDNA cloning, Northern blot, FISH chromosomal mapping","journal":"Cytogenetics and cell genetics","confidence":"Low","confidence_rationale":"Tier 3 — initial cloning and domain identification, no functional mechanistic assay","pmids":["8978778"],"is_preprint":false}],"current_model":"TBCB is a tubulin-folding chaperone that binds α-tubulin intermediates released from the CCT chaperonin and acts together with TBCE to dissociate αβ-tubulin heterodimers in an energy-independent manner driven by steric displacement of β-tubulin; the resulting TBCE–TBCB–α-tubulin ternary complex escorts α-tubulin toward proteasomal degradation, while free β-tubulin is captured by TBCA for recycling, with the TBCE/TBCB+TBCA system collectively setting the critical concentration of free heterodimers and regulating microtubule dynamics; TBCB stability is itself regulated by Gigaxonin-mediated ubiquitination, HSP90 binding, and PAK1-dependent phosphorylation."},"narrative":{"teleology":[{"year":1996,"claim":"Initial cloning of TBCB (then CKAP1) identified a CAP-Gly domain, placing it among cytoskeleton-associated proteins but leaving its biochemical function unknown.","evidence":"cDNA cloning from human fetal brain, Northern blot, FISH mapping","pmids":["8978778"],"confidence":"Low","gaps":["No functional or binding assay performed","CAP-Gly domain role in tubulin interaction not tested","Expression pattern limited to Northern blot"]},{"year":2006,"claim":"Demonstrating that TBCB forms a binary complex with TBCE and greatly enhances heterodimer dissociation established the functional partnership central to tubulin homeostasis, and showed that the products are a TBCE–TBCB–α-tubulin ternary complex plus free β-tubulin captured by TBCA.","evidence":"Overexpression, in vitro dissociation assays, co-immunoprecipitation, and immunofluorescence showing microtubule depolymerization upon TBCB overexpression","pmids":["17184771"],"confidence":"High","gaps":["Structural basis of TBCB–TBCE cooperation unknown","Mechanism of energy-independent dissociation unclear","Physiological stoichiometry of TBCE/TBCB not determined"]},{"year":2008,"claim":"Showing that TBCB directly binds CCT-generated α-tubulin folding intermediates — and that a disease-causing α-tubulin mutation disrupts this interaction — established TBCB as the immediate downstream acceptor of nascent α-tubulin from the chaperonin.","evidence":"In vitro folding assays with CCT, pulldown assays with TBCB, TUBA1A R264C mutagenesis","pmids":["18199681"],"confidence":"High","gaps":["Binding interface between TBCB and α-tubulin not structurally resolved","Whether TBCB functions as monomer or oligomer when receiving α-tubulin unknown"]},{"year":2015,"claim":"The cryo-EM structure of the TBCE–TBCB–α-tubulin ternary complex revealed that heterodimer dissociation is energy-independent, driven by steric clash between TBCE domains and β-tubulin, and that protruding UBL domains suggest a direct route to proteasomal degradation of α-tubulin.","evidence":"Cryo-EM 3D reconstruction, X-ray crystallography of TBCE UBL domain, atomic docking, biochemical dissociation assays","pmids":["25908846"],"confidence":"High","gaps":["Direct proteasome recruitment by UBL domains not experimentally demonstrated","High-resolution atomic model of full complex not achieved","Contribution of TBCB CAP-Gly domain to steric displacement not individually dissected"]},{"year":2017,"claim":"Identification of TBCB post-translational regulation — Gigaxonin-mediated ubiquitination, HSP90-dependent stabilization, and PAK1 phosphorylation — revealed how TBCB protein levels are tuned upstream of its tubulin-destabilizing activity.","evidence":"Co-immunoprecipitation, ubiquitination assays, RNAi, overexpression in cells; HILI/PIWIL2 shown to modulate all three regulatory axes","pmids":["28393858"],"confidence":"Medium","gaps":["Phosphorylation site(s) on TBCB not mapped","In vivo relevance of HILI–TBCB axis outside cancer cell lines not tested","Whether Gigaxonin disease mutations dysregulate TBCB levels in patients not shown"]},{"year":2018,"claim":"Demonstrating that elevated TBCB destabilizes TUBA4A and causes motor axon defects in vivo linked TBCB dosage directly to neuronal cytoskeletal integrity through a miR-1825/TBCB/TUBA4A regulatory axis.","evidence":"Proteomics, transcriptomics, gain/loss-of-function in cell lines, in vivo motor axon phenotype, patient tissue validation","pmids":["30030593"],"confidence":"Medium","gaps":["Whether TBCB excess acts solely through TUBA4A or also other α-tubulin isoforms not resolved","miR-1825 regulation of TBCB not confirmed independently","Specificity of motor neuron vulnerability unclear"]},{"year":2020,"claim":"Discovery that the Salmonella effector SseK1 glycosylates TBCB on arginine residues to stabilize microtubules revealed TBCB as a pathogen target, showing that post-translational modification can switch TBCB from a microtubule-destabilizing to a stabilizing state.","evidence":"Yeast two-hybrid, glycosyltransferase assay, DxD motif mutagenesis, immunofluorescence in HEK293T cells","pmids":["32366039"],"confidence":"Medium","gaps":["Specific arginine residues modified not identified","Mechanism by which glycosylation reverses TBCB's destabilizing activity unclear","Relevance during actual Salmonella infection not demonstrated"]},{"year":2021,"claim":"Showing that colchicine blocks TBCE/TBCB-mediated heterodimer dissociation and that TBCA levels independently control free heterodimer concentration established that the TBCE/TBCB+TBCA system functions as a homeostatic rheostat for soluble tubulin.","evidence":"In vitro dissociation assays with colchicine, TBCA RNAi and overexpression, western blot, colchicine/nocodazole/cycloheximide treatment in cells","pmids":["33968934"],"confidence":"High","gaps":["Whether the system responds to microtubule polymerization state in a feedback loop not shown","Quantitative kinetic parameters of the dissociation reaction not determined"]},{"year":2025,"claim":"Identification of a homozygous TBCB loss-of-function variant causing neurodevelopmental disease — validated in patient fibroblasts, yeast, and Drosophila — established TBCB as essential for CNS development and axonal function in humans.","evidence":"Exome sequencing, patient fibroblast western blot/IF, yeast ALF1 benomyl sensitivity, CRISPR Drosophila climbing/survival assays","pmids":["40856104"],"confidence":"Medium","gaps":["Single family reported; additional kindreds needed","Whether disease mechanism is tubulin destabilization or impaired folding not distinguished","CNS-specific role versus general cytoskeletal requirement not dissected"]},{"year":null,"claim":"It remains unknown how the TBCE–TBCB–α-tubulin complex is delivered to the proteasome, whether the UBL domains directly engage proteasomal receptors, how PAK1 phosphorylation sites modulate TBCB activity, and whether TBCB loss-of-function disease operates through failed tubulin folding, impaired heterodimer turnover, or both.","evidence":"","pmids":[],"confidence":"Low","gaps":["Proteasome engagement by UBL domains not experimentally validated","Phosphorylation sites on TBCB unmapped","Pathomechanism of TBCB deficiency (folding vs. turnover) unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,2,3,7]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,3,7]}],"pathway":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,5,7]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,3]}],"complexes":["TBCE-TBCB-α-tubulin ternary complex"],"partners":["TBCE","TBCA","TUBA1A","TUBA4A","PIWIL2","GAN","HSP90","PAK1"],"other_free_text":[]},"mechanistic_narrative":"TBCB is a tubulin-folding cofactor that captures α-tubulin intermediates released from the CCT chaperonin and cooperates with TBCE to dissociate αβ-tubulin heterodimers through an energy-independent steric-displacement mechanism, forming a TBCE–TBCB–α-tubulin ternary complex that routes α-tubulin toward proteasomal degradation while freed β-tubulin is recycled by TBCA [PMID:18199681, PMID:25908846, PMID:33968934]. This TBCE/TBCB+TBCA system sets the critical concentration of free tubulin heterodimers and thereby regulates microtubule dynamics; elevated TBCB destabilizes microtubules and promotes α-tubulin degradation, causing motor axon defects in vivo [PMID:17184771, PMID:30030593]. TBCB protein stability is controlled by Gigaxonin-mediated ubiquitination, HSP90 binding, and PAK1-dependent phosphorylation [PMID:28393858]. A homozygous loss-of-function TBCB variant causes a neurodevelopmental disorder with impaired motor function, establishing TBCB as essential for normal CNS development and axonal integrity [PMID:40856104]."},"prefetch_data":{"uniprot":{"accession":"Q99426","full_name":"Tubulin-folding cofactor B","aliases":["Cytoskeleton-associated protein 1","Cytoskeleton-associated protein CKAPI","Tubulin-specific chaperone B"],"length_aa":244,"mass_kda":27.3,"function":"Binds to alpha-tubulin folding intermediates after their interaction with cytosolic chaperonin in the pathway leading from newly synthesized tubulin to properly folded heterodimer (PubMed:9265649). Involved in regulation of tubulin heterodimer dissociation. May function as a negative regulator of axonal growth (By similarity)","subcellular_location":"Cytoplasm; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q99426/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TBCB","classification":"Common Essential","n_dependent_lines":1172,"n_total_lines":1208,"dependency_fraction":0.9701986754966887},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"SAR1B","stoichiometry":0.2},{"gene":"TUBA1B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TBCB","total_profiled":1310},"omim":[{"mim_id":"621382","title":"NEURODEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CHILDHOOD-ONSET SPASTIC PARAPLEGIA; NEDBSPG","url":"https://www.omim.org/entry/621382"},{"mim_id":"602529","title":"TUBULIN, ALPHA-1A; TUBA1A","url":"https://www.omim.org/entry/602529"},{"mim_id":"601303","title":"TUBULIN FOLDING COFACTOR B; TBCB","url":"https://www.omim.org/entry/601303"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":386.0}],"url":"https://www.proteinatlas.org/search/TBCB"},"hgnc":{"alias_symbol":["CG22","CKAPI"],"prev_symbol":["CKAP1"]},"alphafold":{"accession":"Q99426","domains":[{"cath_id":"3.10.20.90","chopping":"9-88","consensus_level":"high","plddt":96.1691,"start":9,"end":88},{"cath_id":"2.30.30.190","chopping":"156-230","consensus_level":"high","plddt":96.6544,"start":156,"end":230}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99426","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99426-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99426-F1-predicted_aligned_error_v6.png","plddt_mean":92.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBCB","jax_strain_url":"https://www.jax.org/strain/search?query=TBCB"},"sequence":{"accession":"Q99426","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99426.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99426/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99426"}},"corpus_meta":[{"pmid":"17184771","id":"PMC_17184771","title":"Role of cofactors B (TBCB) and E (TBCE) in tubulin heterodimer dissociation.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17184771","citation_count":63,"is_preprint":false},{"pmid":"18199681","id":"PMC_18199681","title":"A pachygyria-causing alpha-tubulin mutation results in inefficient cycling with CCT and a deficient interaction with TBCB.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18199681","citation_count":40,"is_preprint":false},{"pmid":"30030593","id":"PMC_30030593","title":"Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS.","date":"2018","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/30030593","citation_count":38,"is_preprint":false},{"pmid":"25908846","id":"PMC_25908846","title":"The structure of the complex between α-tubulin, TBCE and TBCB reveals a tubulin dimer dissociation mechanism.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25908846","citation_count":36,"is_preprint":false},{"pmid":"33968934","id":"PMC_33968934","title":"Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33968934","citation_count":19,"is_preprint":false},{"pmid":"28393858","id":"PMC_28393858","title":"HILI destabilizes microtubules by suppressing phosphorylation and Gigaxonin-mediated degradation of TBCB.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28393858","citation_count":15,"is_preprint":false},{"pmid":"8978778","id":"PMC_8978778","title":"Cloning, expression, and mapping of CKAPI, which encodes a putative cytoskeleton-associated protein containing a CAP-GLY domain.","date":"1996","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8978778","citation_count":12,"is_preprint":false},{"pmid":"32366039","id":"PMC_32366039","title":"Tubulin Folding Cofactor TBCB is a Target of the Salmonella Effector Protein SseK1.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32366039","citation_count":7,"is_preprint":false},{"pmid":"37476188","id":"PMC_37476188","title":"High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37476188","citation_count":3,"is_preprint":false},{"pmid":"41570284","id":"PMC_41570284","title":"Multi-omics analysis identifies TBCB as a therapeutic target in sepsis-induced liver injury.","date":"2026","source":"International journal of surgery (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/41570284","citation_count":0,"is_preprint":false},{"pmid":"40856104","id":"PMC_40856104","title":"A founder variant in TBCB is associated with global developmental delay, autism spectrum, and spastic paraparesis.","date":"2025","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40856104","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6672,"output_tokens":2489,"usd":0.028675},"stage2":{"model":"claude-opus-4-6","input_tokens":5884,"output_tokens":2700,"usd":0.14538},"total_usd":0.174055,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"TBCB forms a binary complex with TBCE that greatly enhances the efficiency of TBCE to dissociate tubulin heterodimers both in vivo and in vitro; TBCE, TBCB, and α-tubulin form a ternary complex after heterodimer dissociation, while free β-tubulin is recovered by TBCA.\",\n      \"method\": \"Overexpression, in vitro dissociation assays, co-immunoprecipitation, biochemical fractionation\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal complex formation confirmed by multiple biochemical methods, in vitro and in vivo, replicated in subsequent studies\",\n      \"pmids\": [\"17184771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Overexpression of TBCB depolymerizes microtubules in vivo, demonstrating a direct role for TBCB in regulating microtubule dynamics.\",\n      \"method\": \"Overexpression in cells, immunofluorescence microscopy of microtubule network\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean overexpression with defined cellular phenotype, single lab\",\n      \"pmids\": [\"17184771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TBCB binds CCT-generated folding intermediates of α-tubulin; the pachygyria-causing R264C mutation in TUBA1A fails to stably interact with TBCB, contributing to deficient tubulin heterodimer formation.\",\n      \"method\": \"In vitro folding assays with CCT, pulldown/binding assays with TBCB, mutagenesis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis establishing direct TBCB-αtubulin interaction and functional consequence\",\n      \"pmids\": [\"18199681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cryo-EM structure of the human TBCE–TBCB–α-tubulin (αEB) ternary complex reveals that heterodimer dissociation is energy-independent and is driven by steric clash between β-tubulin and the TBCE CAP-Gly and LRR domains; UBL domains of the chaperones protrude in a configuration suggesting direct interaction with the proteasome for α-tubulin degradation.\",\n      \"method\": \"Electron microscopy, image processing (3D reconstruction), X-ray crystallography of TBCE UBL domain, atomic docking, biochemical dissociation assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure determined by EM with atomic docking and validated by biochemical assays, multiple orthogonal methods\",\n      \"pmids\": [\"25908846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HILI (PIWIL2) interacts with TBCB and inhibits Gigaxonin-mediated ubiquitination and proteasomal degradation of TBCB by promoting HSP90–TBCB binding and blocking Gigaxonin–TBCB interaction; HILI also reduces PAK1-induced phosphorylation of TBCB, collectively increasing TBCB levels and destabilizing microtubules.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, RNAi knockdown, overexpression, western blot, immunofluorescence\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — multiple co-IP and functional assays from single lab identifying post-translational regulation of TBCB\",\n      \"pmids\": [\"28393858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Elevated TBCB leads to depolymerization and degradation of α-tubulin TUBA4A; excess TBCB causes motor axon defects in an in vivo model, placing TBCB upstream of TUBA4A stability in a miR-1825/TBCB/TUBA4A pathway.\",\n      \"method\": \"Proteomic and transcriptomic analysis, loss-of-function/gain-of-function in cell lines, in vivo motor axon phenotype assay, patient tissue validation\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, cell-based, in vivo) from single lab\",\n      \"pmids\": [\"30030593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The Salmonella effector SseK1 directly binds TBCB (identified by yeast two-hybrid) and catalyzes N-acetylglucosamine addition to arginine residues on TBCB; this modification promotes microtubule cytoskeleton stabilization in host cells, and requires the conserved DxD catalytic motif of SseK1.\",\n      \"method\": \"Yeast two-hybrid, glycosyltransferase activity assay, mutagenesis of DxD motif, immunofluorescence of microtubule network in HEK293T cells\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — enzymatic activity demonstrated with mutagenesis and functional readout, single lab\",\n      \"pmids\": [\"32366039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Colchicine inhibits tubulin heterodimer dissociation by the TBCE/TBCB complex in vitro, likely by interfering with TBCE–tubulin dimer interactions; this leads to accumulation of free TBCA and reduced tubulin heterodimer recycling. Manipulation of TBCA levels by RNAi or overexpression decreases tubulin heterodimer levels, indicating the TBCE/TBCB+TBCA system controls the critical concentration of free tubulin heterodimers.\",\n      \"method\": \"In vitro dissociation assays with colchicine, RNAi knockdown and overexpression of TBCA, western blot, human cell treatment with colchicine/nocodazole/cycloheximide\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical assays with mechanistic dissection, supported by cell-based loss/gain-of-function, multiple orthogonal methods\",\n      \"pmids\": [\"33968934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A homozygous p.Tyr197Asn variant in TBCB reduces TBCB protein levels in patient fibroblasts and causes a loss-of-function phenotype (benomyl hypersensitivity in the yeast ortholog ALF1); the homologous Drosophila mutant shows reduced survival and impaired motor function, establishing that TBCB is required for normal axonal function and CNS development.\",\n      \"method\": \"Exome sequencing, western blot and immunofluorescence in patient fibroblasts, yeast ALF1 ortholog benomyl sensitivity assay, CRISPR-Cas9 Drosophila mutant climbing/survival assay\",\n      \"journal\": \"Genetics in medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function validated in patient cells and two model organisms with defined phenotypic readouts\",\n      \"pmids\": [\"40856104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TBCB (CKAP1) was cloned from human fetal brain cDNA and found to encode a protein containing a CAP-Gly domain conserved among cytoskeleton-associated proteins; the gene was mapped to chromosome 19q13.11–q13.12.\",\n      \"method\": \"cDNA cloning, Northern blot, FISH chromosomal mapping\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — initial cloning and domain identification, no functional mechanistic assay\",\n      \"pmids\": [\"8978778\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TBCB is a tubulin-folding chaperone that binds α-tubulin intermediates released from the CCT chaperonin and acts together with TBCE to dissociate αβ-tubulin heterodimers in an energy-independent manner driven by steric displacement of β-tubulin; the resulting TBCE–TBCB–α-tubulin ternary complex escorts α-tubulin toward proteasomal degradation, while free β-tubulin is captured by TBCA for recycling, with the TBCE/TBCB+TBCA system collectively setting the critical concentration of free heterodimers and regulating microtubule dynamics; TBCB stability is itself regulated by Gigaxonin-mediated ubiquitination, HSP90 binding, and PAK1-dependent phosphorylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TBCB is a tubulin-folding cofactor that captures α-tubulin intermediates released from the CCT chaperonin and cooperates with TBCE to dissociate αβ-tubulin heterodimers through an energy-independent steric-displacement mechanism, forming a TBCE–TBCB–α-tubulin ternary complex that routes α-tubulin toward proteasomal degradation while freed β-tubulin is recycled by TBCA [PMID:18199681, PMID:25908846, PMID:33968934]. This TBCE/TBCB+TBCA system sets the critical concentration of free tubulin heterodimers and thereby regulates microtubule dynamics; elevated TBCB destabilizes microtubules and promotes α-tubulin degradation, causing motor axon defects in vivo [PMID:17184771, PMID:30030593]. TBCB protein stability is controlled by Gigaxonin-mediated ubiquitination, HSP90 binding, and PAK1-dependent phosphorylation [PMID:28393858]. A homozygous loss-of-function TBCB variant causes a neurodevelopmental disorder with impaired motor function, establishing TBCB as essential for normal CNS development and axonal integrity [PMID:40856104].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Initial cloning of TBCB (then CKAP1) identified a CAP-Gly domain, placing it among cytoskeleton-associated proteins but leaving its biochemical function unknown.\",\n      \"evidence\": \"cDNA cloning from human fetal brain, Northern blot, FISH mapping\",\n      \"pmids\": [\"8978778\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional or binding assay performed\", \"CAP-Gly domain role in tubulin interaction not tested\", \"Expression pattern limited to Northern blot\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that TBCB forms a binary complex with TBCE and greatly enhances heterodimer dissociation established the functional partnership central to tubulin homeostasis, and showed that the products are a TBCE–TBCB–α-tubulin ternary complex plus free β-tubulin captured by TBCA.\",\n      \"evidence\": \"Overexpression, in vitro dissociation assays, co-immunoprecipitation, and immunofluorescence showing microtubule depolymerization upon TBCB overexpression\",\n      \"pmids\": [\"17184771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TBCB–TBCE cooperation unknown\", \"Mechanism of energy-independent dissociation unclear\", \"Physiological stoichiometry of TBCE/TBCB not determined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showing that TBCB directly binds CCT-generated α-tubulin folding intermediates — and that a disease-causing α-tubulin mutation disrupts this interaction — established TBCB as the immediate downstream acceptor of nascent α-tubulin from the chaperonin.\",\n      \"evidence\": \"In vitro folding assays with CCT, pulldown assays with TBCB, TUBA1A R264C mutagenesis\",\n      \"pmids\": [\"18199681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface between TBCB and α-tubulin not structurally resolved\", \"Whether TBCB functions as monomer or oligomer when receiving α-tubulin unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The cryo-EM structure of the TBCE–TBCB–α-tubulin ternary complex revealed that heterodimer dissociation is energy-independent, driven by steric clash between TBCE domains and β-tubulin, and that protruding UBL domains suggest a direct route to proteasomal degradation of α-tubulin.\",\n      \"evidence\": \"Cryo-EM 3D reconstruction, X-ray crystallography of TBCE UBL domain, atomic docking, biochemical dissociation assays\",\n      \"pmids\": [\"25908846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct proteasome recruitment by UBL domains not experimentally demonstrated\", \"High-resolution atomic model of full complex not achieved\", \"Contribution of TBCB CAP-Gly domain to steric displacement not individually dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of TBCB post-translational regulation — Gigaxonin-mediated ubiquitination, HSP90-dependent stabilization, and PAK1 phosphorylation — revealed how TBCB protein levels are tuned upstream of its tubulin-destabilizing activity.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitination assays, RNAi, overexpression in cells; HILI/PIWIL2 shown to modulate all three regulatory axes\",\n      \"pmids\": [\"28393858\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphorylation site(s) on TBCB not mapped\", \"In vivo relevance of HILI–TBCB axis outside cancer cell lines not tested\", \"Whether Gigaxonin disease mutations dysregulate TBCB levels in patients not shown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that elevated TBCB destabilizes TUBA4A and causes motor axon defects in vivo linked TBCB dosage directly to neuronal cytoskeletal integrity through a miR-1825/TBCB/TUBA4A regulatory axis.\",\n      \"evidence\": \"Proteomics, transcriptomics, gain/loss-of-function in cell lines, in vivo motor axon phenotype, patient tissue validation\",\n      \"pmids\": [\"30030593\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TBCB excess acts solely through TUBA4A or also other α-tubulin isoforms not resolved\", \"miR-1825 regulation of TBCB not confirmed independently\", \"Specificity of motor neuron vulnerability unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that the Salmonella effector SseK1 glycosylates TBCB on arginine residues to stabilize microtubules revealed TBCB as a pathogen target, showing that post-translational modification can switch TBCB from a microtubule-destabilizing to a stabilizing state.\",\n      \"evidence\": \"Yeast two-hybrid, glycosyltransferase assay, DxD motif mutagenesis, immunofluorescence in HEK293T cells\",\n      \"pmids\": [\"32366039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific arginine residues modified not identified\", \"Mechanism by which glycosylation reverses TBCB's destabilizing activity unclear\", \"Relevance during actual Salmonella infection not demonstrated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showing that colchicine blocks TBCE/TBCB-mediated heterodimer dissociation and that TBCA levels independently control free heterodimer concentration established that the TBCE/TBCB+TBCA system functions as a homeostatic rheostat for soluble tubulin.\",\n      \"evidence\": \"In vitro dissociation assays with colchicine, TBCA RNAi and overexpression, western blot, colchicine/nocodazole/cycloheximide treatment in cells\",\n      \"pmids\": [\"33968934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the system responds to microtubule polymerization state in a feedback loop not shown\", \"Quantitative kinetic parameters of the dissociation reaction not determined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identification of a homozygous TBCB loss-of-function variant causing neurodevelopmental disease — validated in patient fibroblasts, yeast, and Drosophila — established TBCB as essential for CNS development and axonal function in humans.\",\n      \"evidence\": \"Exome sequencing, patient fibroblast western blot/IF, yeast ALF1 benomyl sensitivity, CRISPR Drosophila climbing/survival assays\",\n      \"pmids\": [\"40856104\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single family reported; additional kindreds needed\", \"Whether disease mechanism is tubulin destabilization or impaired folding not distinguished\", \"CNS-specific role versus general cytoskeletal requirement not dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how the TBCE–TBCB–α-tubulin complex is delivered to the proteasome, whether the UBL domains directly engage proteasomal receptors, how PAK1 phosphorylation sites modulate TBCB activity, and whether TBCB loss-of-function disease operates through failed tubulin folding, impaired heterodimer turnover, or both.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Proteasome engagement by UBL domains not experimentally validated\", \"Phosphorylation sites on TBCB unmapped\", \"Pathomechanism of TBCB deficiency (folding vs. turnover) unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 2, 3, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 3, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 5, 7]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"complexes\": [\n      \"TBCE-TBCB-α-tubulin ternary complex\"\n    ],\n    \"partners\": [\n      \"TBCE\",\n      \"TBCA\",\n      \"TUBA1A\",\n      \"TUBA4A\",\n      \"PIWIL2\",\n      \"GAN\",\n      \"HSP90\",\n      \"PAK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}